KORU Medical Systems Inc.’s recently made public that its Director Manko Joseph M. Jr. acquired Company’s shares for reported $26466.0 on Aug 21. In the deal valued at $2.65 per share,10,000 shares were bought. As a result of this transaction, Manko Joseph M. Jr. now holds 7,458,434 shares worth roughly $ 19.54 million.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
Then, Manko Joseph M. Jr. bought 10,000 shares, generating $25,407 in total proceeds. Upon buying the shares at $2.54, the Director now owns 7,448,434 shares.
Before that, Tharby Linda M bought 5,272 shares. KORU Medical Systems Inc. shares valued at $13,336 were divested by the President and CEO at a price of $2.53 per share. As a result of the transaction, Tharby Linda M now holds 1,056,676 shares, worth roughly $2.77 million.
Piper Sandler upgraded its KORU Medical Systems Inc. [KRMD] rating to an Overweight from a a Neutral in a research note published on Friday, November 10, 2022; the price target was increased to $3.50 from $3. PT values the company’s stock at a premium of 25.14 to its Friday closing price.
Price Performance Review of KRMD
On Friday, KORU Medical Systems Inc. [NASDAQ:KRMD] saw its stock remained unchanged to $2.62. On the same session, the stock had its day’s lowest price of $2.52, but rose to a high of $2.67. Over the last five days, the stock has gained 1.16%. KORU Medical Systems Inc. shares have fallen nearly -26.61% since the year began. Nevertheless, the stocks have risen 6.07% over the past one year. While a 52-week high of $4.48 was reached on 04/28/23, a 52-week low of $2.13 was recorded on 08/10/23. SMA at 50 days reached $2.85, while 200 days put it at $3.55. A total of 60326.0 shares were traded, compared to the trading of 72300.0 shares in the previous session.
Levels Of Support And Resistance For KRMD Stock
The 24-hour chart illustrates a support level at 2.54, which if violated will result in even more drops to 2.45. On the upside, there is a resistance level at 2.69. A further resistance level may holdings at 2.75. The Relative Strength Index (RSI) on the 14-day chart is 46.33, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.03, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 52.98%. Stochastics %K at 56.85% indicates the stock is a holding.
How much short interest is there in KORU Medical Systems Inc.?
A steep rise in short interest was recorded in KORU Medical Systems Inc. stocks on Aug 14, 2023, dropping by 50950.0 shares to a total of 0.33 million shares. Yahoo Finance data shows the prior-month short interest on Jul 13, 2023 was 0.38 million shares. There was a decline of -15.27%, which implies that there is a negative sentiment for the stock. In spite of short shares comprising just 1.21% of the overall stock float, the days-to-cover ratio (short ratio) fell to 3.19.
KORU Medical Systems Inc. [KRMD] – Who Are The Largest Shareholders?
In filings from Horton Capital Management LLC, it is revealed that the company now owns 9,803,092 shares, or roughly 21.49% of the outstanding KRMD shares. In other words, the investor’s shares have risen by 20,000 from its previous 13-F filing of 9783092.0. Additionally, First Light Asset Management LLC decreased -14.40% of its stake after which the total value it holdings stand at $13,779,061. Over the last quarter, The Vanguard Group, Inc. purchased 87,960 shares of KORU Medical Systems Inc., while BlackRock Fund Advisors bought 930,256 shares. At present, Parkman Healthcare Partners LLC is holding 899,063 shares valued at $2.34 million. B. Riley Asset Management LLC owned 811,925 shares of the company at the time of its most recent 13F filing, worth $2.11 million.
However, 3 analysts have rated KRMD stock as a Buy in their predictions for 2023.